Position in LFCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,050
-$225 QoQ
Shares Held
200
-41.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 98 holders
Holding Since
Sep 2021
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $44,501,431 across 71 Drug Manufacturers - Specialty & Generic names. LFCR ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
217,692 | $7,375,403 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
10,752 | $5,825,755 | |
| 3 | ZTS |
Zoetis Inc.
|
76,124 | $5,470,270 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
110,062 | $3,815,848 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
22,617 | $3,811,866 | |
| 6 | LQDA |
Liquidia Corp
|
42,666 | $3,401,759 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
134,620 | $2,330,270 | |
| 8 | VTRS |
Viatris Inc
|
116,264 | $1,846,269 |
All Filings in LFCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,050 | 200 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,275 | 343 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $390 | 53 | Shares | Defined | 2025-11-14 | |
| 2023-12-31 | $3,397 | 549 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,011 | 134 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,295 | 134 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $1,545 | 409 | Shares | Defined | 2023-05-12 | |
| 2021-09-30 | $3,079 | 334 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||